Legacy Financial Advisors, Inc. Abbott Laboratories Transaction History

Legacy Financial Advisors, Inc.

$515 Million
Q3 2024

A detailed history of Legacy Financial Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Legacy Financial Advisors, Inc. holds 7,485 shares of ABT stock, worth $858,978. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,485

Previous 6,916 8.23%

Holding current value

$858,978

Previous $718,000 18.8%

% of portfolio

0.17%

Previous 0.14%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $56,939 - $67,215	569 Added 8.23%	7,485 $853,000
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $24,880 - $27,772	247 Added 3.7%	6,916 $718,000
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $20,699 - $22,861	-189 Reduced 2.76%	6,669 $757,000
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $78,284 - $95,827	868 Added 14.49%	6,858 $754,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $4,203 - $5,043	-44 Reduced 0.73%	5,990 $580,000
Q2 2023 Aug 08, 2023	BUY	$100.78 - $112.29 $29,024 - $32,339	288 Added 5.01%	6,034 $657,000
Q1 2023 May 03, 2023	SELL	$96.86 - $114.01 $4,649 - $5,472	-48 Reduced 0.83%	5,746 $581,000
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $75,952 - $89,104	799 Added 16.0%	5,794 $636,000
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $32,801 - $37,978	339 Added 7.28%	4,995 $483,000
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $81,349 - $98,325	-797 Reduced 14.62%	4,656 $506,000
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $39,792 - $48,524	349 Added 6.84%	5,453 $645,000
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $14,556 - $17,823	-126 Reduced 2.41%	5,104 $718,000
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $104,877 - $116,024	899 Added 20.76%	5,230 $618,000
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $46,441 - $54,668	-439 Reduced 9.2%	4,331 $502,000
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $4,680 - $5,513	-43 Reduced 0.89%	4,770 $572,000
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $37,800 - $41,191	360 Added 8.08%	4,813 $526,000
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $408,072 - $495,574	4,453 New	4,453 $485,000
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $267,173 - $390,680	-4,253 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $1,727 - $1,922	22 Added 0.52%	4,253 $369,000
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $24,633 - $26,710	301 Added 7.66%	4,231 $354,000
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $7,725 - $9,010	106 Added 2.77%	3,930 $331,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $30,990 - $37,468	468 Added 13.95%	3,824 $306,000
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $32,058 - $36,318	-489 Reduced 12.72%	3,356 $243,000
Q2 2018 Jul 17, 2018	BUY	$57.57 - $63.54 $4,663 - $5,146	81 Added 2.15%	3,845 $242,000
Q1 2018 Apr 12, 2018	BUY	$56.27 - $63.62 $5,176 - $5,853	92 Added 2.51%	3,764 $222,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $197,112 - $211,029	3,672	3,672 $209,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.

Account

Legacy Financial Advisors, Inc. Abbott Laboratories Transaction History